Sign in
CompletedNo phase

H. Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study

Key facts

Who runs it
Nanjing First Hospital, Nanjing Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
5,218 people enrolled
Started
1 May 2024
Ended
1 Mar 2026
Type of study
Observational, 2 groups
Treatments tested
  • No intervention. This is an observational study.
Record updated
16 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age ≥18 years
  • Completed annual health examination at Nanjing First Hospital Health Management Center between May 1, 2024 and May 1, 2025
  • Underwent 13C or 14C urea breath test for H. pylori status assessment
  • Complete data on the following measurements: height, weight, waist circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose, triglycerides, and high-density lipoprotein cholesterol
  • No missing data on key study variables

Who cannot take part

  • History of severe liver dysfunction
  • History of severe kidney dysfunction
  • History of malignancy
  • Missing any of the following primary metabolic indicators: waist circumference, blood pressure (systolic/diastolic), fasting blood glucose, triglycerides, or HDL-cholesterol
  • Missing key data on H. pylori test results (13C or 14C urea breath test)
  • Pregnancy or lactation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This retrospective cross-sectional study evaluates the association between Helicobacter pylori infection and metabolic syndrome using health examination data from 5,218 adults at Nanjing First Hospital. Participants are divided into H. pylori-positive and negative groups based on urea breath test results. The primary outcome is metabolic syndrome prevalence (CDS 2020 criteria). Multivariable logistic regression will be used to assess the independent association, with subgroup analyses by age and sex.

The 2 groups in the trial

  • H. pylori Positive Group

    Participants with positive 13C or 14C urea breath test result

    Treatment: No intervention. This is an observational study.

  • H. pylori Negative Group

    Participants with negative 13C or 14C urea breath test result

    Treatment: No intervention. This is an observational study.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Association Between Helicobacter Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study
Record updated
16 June 2026